why choose us

First received: June 29, 2023

Clinical Trial: Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lower Eyelid Steatoblepharon

Study Type: INTERVENTIONAL


Official Title: Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon

Brief Summary: This trial is testing a drug to see if multiple injections to the undereye bags of selected patients decreases the volume of the eyebags as compared to placebo.Subjects will be randomized to receive either one of two doses of POLAT-001 or placebo.POLAT-001 will be injected into the eyebags at three of the visits.Each subject will attend 7-10 clinic visits over 98 to 140 days total to assess efficacy and safety.

Read more